stella
beta
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms — Stella
Recruiting
Back to Neoplasms trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
The University of Texas M. D. Anderson Cancer Center, Houston, Texas
View full record on ClinicalTrials.gov